Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Favorite
Sebastian Maier
Lilly Deutschland GmbH, Germany
Poster(s):
P1210 - Subcutaneous Mirikizumab Maintenance Treatment Over 40 Weeks Leads to Incremental Improvements in Rates of Clinical Remission and Endoscopic Response: Results From the Phase 3 VIVID-1 Study
Sunday, October 26, 2025
3:30 PM - 7:00 PM
MT